Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Johnson and Johnson
Julphar
Citi
Chubb
US Department of Justice
Express Scripts
Mallinckrodt

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017922

« Back to Dashboard

NDA 017922 describes DDAVP (NEEDS NO REFRIGERATION), which is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the DDAVP (NEEDS NO REFRIGERATION) profile page.

The generic ingredient in DDAVP (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 017922
Suppliers and Packaging for NDA: 017922
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DDAVP desmopressin acetate SOLUTION;NASAL 017922 NDA sanofi-aventis U.S. LLC 0075-2450 E 0075-2450-01
DDAVP desmopressin acetate SOLUTION;NASAL 017922 NDA sanofi-aventis U.S. LLC 0075-2452 E 0075-2452-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;NASALStrength0.01%
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 6, 1989TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrength0.01MG/SPRAY
Approval Date:Aug 7, 1996TE:ABRLD:Yes

Expired US Patents for NDA 017922

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Dow
Farmers Insurance
Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Mallinckrodt
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.